{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:23:50Z","timestamp":1747200230587,"version":"3.40.5"},"reference-count":43,"publisher":"Media Sphere Publishing House","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Foren. Med. Expert."],"published-print":{"date-parts":[[2024,4,23]]},"abstract":"<jats:p>Over several months, 14 people were admitted in 6 hospitals with severe symptoms of intoxication with psychoactive substances as a result of mass poisoning. All symptoms occurred after taking a drink that contained crushed phenazepam tablets. Samples of blood (n=10) and urine (n=6) taken from 14 sufferers for forensic, chemical and toxicological examination were analyzed using the HPLC-MS\/MS method. Phenazepam was detected in the biomaterial of all 14 patients. Other psychoactive substances (baclofen, pregabalin, chlorprothixene, chlorpromazine, phenibut, tramadol, diazepam), narcotic substances and ethanol were also found in the sufferers. The phenazepam concentration in the blood was in the range of 109.75\u2014786.50 ng\/ml, in the urine \u2014 8.97\u2014101.28 ng\/ml. The pharmacokinetic and toxicokinetic characteristics of toxicants as well as additional factors characterizing the phenotype of the sufferer in addition to drug\u2019s content in the biological material must be taken into account to determine the toxicity level of phenazepam against the background of combined action with other psychoactive substances.<\/jats:p>","DOI":"10.17116\/sudmed20246701147","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T09:07:23Z","timestamp":1707901643000},"page":"47","source":"Crossref","is-referenced-by-count":1,"title":["Personalized character of toxic effects through mass nonlethal poisoning by phenazepam and other psychoactive substances"],"prefix":"10.17116","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0689-7704","authenticated-orcid":false,"given":"V.D.","family":"Akimova","sequence":"first","affiliation":[{"name":"Russian Center of Forensic Medical Expertise","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-4253","authenticated-orcid":false,"given":"S.S.","family":"Barsegyan","sequence":"additional","affiliation":[{"name":"Russian Center of Forensic Medical Expertise","place":["Moscow, Russia"]},{"name":"Serbsky Federal Medical Research Centre of Psychiatry and Narcology","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7297-980X","authenticated-orcid":false,"given":"T.V.","family":"Pleteneva","sequence":"additional","affiliation":[{"name":"Peoples\u2019 Friendship University of Russia","place":["Moscow, Russia"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6743","reference":[{"key":"key-10.17116\/sudmed20246701147-1","unstructured":"Barsegyan SS, Salomatin EM, Pleteneva TV, Maksimova TV, Dolinkin AO. Metodicheskie rekomendatsii po validatsii analiticheskikh metodik, ispolzuemykh v sudebno-khimicheskom i khimiko-toksikologicheskom analize biologicheskogo materiala. M.: RTsSME; 2014. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-2","unstructured":"Postanovlenie Pravitelstva Rossijskoj Federatsii ot 18 sentyabrya 2020 g. N 1495 \u00abO vnesenii izmenenij v nekotorye akty Pravitelstva Rossijskoj Federatsii\u00bb. Sobranie zakonodatelstva RF. Moskva. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-3","unstructured":"Kukes VG. Klinicheskaya farmakologiya. M.: GEOTAR-Media; 2006. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-4","unstructured":"Mashkovskii MD. Lekarstvennye sredstva. M.: Novaya volna; 2012. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-5","unstructured":"Bazhin AA. Spravochnik po psikhofarmakologii. SPb.: SpetsLit; 2009. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-6","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2012.02.006"},{"key":"key-10.17116\/sudmed20246701147-7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jflm.2011.12.014"},{"key":"key-10.17116\/sudmed20246701147-8","doi-asserted-by":"publisher","DOI":"10.1007\/BF00833255"},{"key":"key-10.17116\/sudmed20246701147-9","unstructured":"Seredenin SB, Voronina TA, Neznamov GG, Zherdev VP. Fenazepam: 25 let v meditsinskoi praktike. M.: Nauka; 2007. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-10","unstructured":"Phenazepam. Pre-review report. World Health Organization, Expert committee on drug dependence, thirty-seventh meeting. Geneva. 2015. Accessed Jul 20, 2017.  https:\/\/www.who.int\/medicines\/access\/controlled-substances\/5.8_Phenazepam_PR1.pdf?ua=1"},{"key":"key-10.17116\/sudmed20246701147-11","unstructured":"Maksutova EL, Sariev AK, Zherdev VP, Voronina TA, Zheleznova EV. The pharmacokinetic characteristics of fenazepam in epileptics. Eksperimental\u2019naia i klinicheskaia farmakologiia. 1994;57(2):16-18"},{"key":"key-10.17116\/sudmed20246701147-12","doi-asserted-by":"crossref","unstructured":"Chekulaev MI, Maksimova TV, Barsegyan SS. Danger of phenazepam as street drug. Health & education millennium. 2015;17(2):85-87. (In Russ.)","DOI":"10.1353\/hah.2015.0007"},{"key":"key-10.17116\/sudmed20246701147-13","doi-asserted-by":"publisher","DOI":"10.1007\/BF03189565"},{"key":"key-10.17116\/sudmed20246701147-14","doi-asserted-by":"publisher","DOI":"10.21265\/PSYPH.2020.37.97.003"},{"key":"key-10.17116\/sudmed20246701147-15","doi-asserted-by":"publisher","DOI":"10.1007\/bf02682012"},{"key":"key-10.17116\/sudmed20246701147-16","unstructured":"Instruktsiya po meditsinskomu primeneniyu preparata Fenazepam\u00ae tabletki (LSR-001772\/09). (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-17","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkx031"},{"key":"key-10.17116\/sudmed20246701147-18","unstructured":"Baselt RC. Disposition of Toxic Drugs and Chemicals in Man, 9th edition. Seal Beach, CA: Biomedical Publications; 2011"},{"key":"key-10.17116\/sudmed20246701147-19","doi-asserted-by":"crossref","unstructured":"Litvin AA, Kolyvanov GB, Zherdev VP, Arzamastsev AP. Relationship between physicochemical characteristics and pharmacokinetic parameters of 1,4-benzodiazepine derivatives. Khimiko-farmatsevticheskii zhurnal. 2004;38(11):3-5. (In Russ.)","DOI":"10.1007\/s11094-005-0034-y"},{"key":"key-10.17116\/sudmed20246701147-20","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bks080"},{"key":"key-10.17116\/sudmed20246701147-21","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-012-1361-z"},{"key":"key-10.17116\/sudmed20246701147-22","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkaa043"},{"key":"key-10.17116\/sudmed20246701147-23","doi-asserted-by":"publisher","DOI":"10.1177\/20503121211022197"},{"key":"key-10.17116\/sudmed20246701147-24","doi-asserted-by":"publisher","DOI":"10.1097\/01.ftd.0000158874.54100.1a"},{"key":"key-10.17116\/sudmed20246701147-25","doi-asserted-by":"publisher","DOI":"10.17116\/anaesthesiology201806122"},{"key":"key-10.17116\/sudmed20246701147-26","doi-asserted-by":"publisher","DOI":"10.17816\/RCF14334-45"},{"key":"key-10.17116\/sudmed20246701147-27","doi-asserted-by":"publisher","DOI":"10.1038\/44579"},{"key":"key-10.17116\/sudmed20246701147-28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1530-0277.2010.01273.x"},{"key":"key-10.17116\/sudmed20246701147-29","unstructured":"Roehrs T, Roth T. Sleep, sleepiness, and alcohol use. Alcohol research & health: the journal of the National Institute on Alcohol Abuse and Alcoholism. 2001;25(2):101-109"},{"key":"key-10.17116\/sudmed20246701147-30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00211.x"},{"key":"key-10.17116\/sudmed20246701147-31","doi-asserted-by":"crossref","unstructured":"Woodward RM, Polenzani L, Miledi R. Characterization of bicuculline\/baclofen-insensitive (rho-like) gamma-aminobutyric acid receptors expressed in Xenopus oocytes. II. Pharmacology of gamma-aminobutyric acidA and gamma-aminobutyric acidB receptor agonists and antagonists. Molecular pharmacology. 1993;43(4):609-625","DOI":"10.1016\/S0026-895X(25)13444-5"},{"key":"key-10.17116\/sudmed20246701147-32","doi-asserted-by":"publisher","DOI":"10.15360\/1813-9779-2020-4-60-71"},{"key":"key-10.17116\/sudmed20246701147-33","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh2017891281-85"},{"key":"key-10.17116\/sudmed20246701147-34","unstructured":"Derimedved LV, Pertsev IM, Shuvanova EV, Zupanets IA, Khomenko VN. Vzaimodeistvie lekarstv i effektivnost farmakoterapii. Kharkov: Megapolis; 2001. (In Russ.)"},{"key":"key-10.17116\/sudmed20246701147-35","doi-asserted-by":"publisher","DOI":"10.1007\/BF01053580"},{"key":"key-10.17116\/sudmed20246701147-36","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90309-9"},{"key":"key-10.17116\/sudmed20246701147-37","doi-asserted-by":"publisher","DOI":"10.1007\/BF00804771"},{"key":"key-10.17116\/sudmed20246701147-38","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1993.tb18412.x"},{"key":"key-10.17116\/sudmed20246701147-39","doi-asserted-by":"publisher","DOI":"10.1007\/BF01899734"},{"key":"key-10.17116\/sudmed20246701147-40","doi-asserted-by":"publisher","DOI":"10.1515\/dmpt-2017-0036"},{"key":"key-10.17116\/sudmed20246701147-41","doi-asserted-by":"publisher","DOI":"10.1002\/dta.1790"},{"key":"key-10.17116\/sudmed20246701147-42","unstructured":"Clinical Drug Interaction Studies \u2014 Cytochrome P450 Enzyme- and Transporter-Mediated Drug Interactions Guidance for Industry. Accessed January 5, 2020.  https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-drug-interaction-studies-cytochrome-p450-enzyme-and-transporter-mediated-drug-interactions"},{"key":"key-10.17116\/sudmed20246701147-43","unstructured":"US Food & Drug Administration. Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Accessed December 12, 2023.  https:\/\/www.fda.gov"}],"container-title":["Forensic Medical Expertise"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T12:36:53Z","timestamp":1745411813000},"score":1,"resource":{"primary":{"URL":"https:\/\/mediasphera.ru\/issues\/sudebno-meditsinskaya-ekspertiza\/2024\/1\/1003945212024011047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,14]]}},"alternative-id":["10.17116\/sudmed20246701147"],"URL":"https:\/\/doi.org\/10.17116\/sudmed20246701147","relation":{},"ISSN":["0039-4521"],"issn-type":[{"type":"print","value":"0039-4521"}],"subject":[],"published":{"date-parts":[[2024,4,23]]}}}